Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1
2(50.0%)
N/A
2(50.0%)
4Total
Phase 1(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06176066Phase 1Recruiting

PH Sensitive MRI Based Resections of Glioblastoma

Role: collaborator

NCT02701153Not ApplicableRecruiting

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

Role: collaborator

NCT03824132Not ApplicableCompleted

LOL: It's All Improv After Cancer!™

Role: collaborator

NCT01438320Phase 1Completed

Q-Trial in Patients With Hepatitis C

Role: collaborator

All 4 trials loaded